Commandité
Novo Nordisk launches Wegovy in India, targets obesity treatment market, offers semaglutide-based weekly injection
Posté
Novo Nordisk has launched Wegovy in India, an anti-obesity drug aimed at managing weight and reducing cardiovascular risks. Priced between Rs 17,345 and Rs 26,050 per month, the injectable drug targets India's large obese population. The company aims to create awareness and collaborate with stakeholders to combat obesity, citing its significant impact on India's GDP.
Rechercher
Catégories
- National
- International
- Business
- Technology
- Health
- Éducation
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Lire la suite
Displaced families of Koshi Tappu submit petition to Prime Minister for compensation
KATHMANDU: Representatives of families displaced by the expansion of the Koshi Tappu Wildlife...
Gill 'didn't quite have that on-field aura' as Kohli, Rohit: Nasser Hussain
Following India's defeat in the Leeds Test, former England captain Nasser Hussain critiqued...
Prachanda raises alarm over bill tampering in parliament
KATHMANDU: Pushpa Kamal Dahal ‘Prachanda’, chair of Maoist Centre, has voiced serious...
© 2025 Dununu.com : Circle of Life - Santan Social Network
French
